Endoscopic submucosal dissection for esophageal cancer behind a tracheoesophageal voice prosthesis.

Authors:
Tani Y; Higashino K; Kanesaka T; Aoki K; Fujii T and 2 more

Journal:
Endoscopy

Publication Year: 2024

DOI:
10.1055/a-2254-7503

PMCID:
PMC10869231

PMID:
38359888

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Endoscopy

Abbreviation: Endoscopy

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Access to the left intrahepatic bile duct using an endoscopic ultrasound-guided rendezvous techniqu…
Hayashi N; Entani T; Matsuno J and 1 more (2024) - Transparency Score: 2/6
Anorectal melanoma presenting as a polypoid lesion.
Luo Q; Ye L; Liang M and 3 more (2024) - Transparency Score: 3/6
A novel hood with a small-caliber tip and two traction strings for endoscopic submucosal dissection.
Fujita K; Saito Y. (2024) - Transparency Score: 2/6
Antegrade stenting using a new covered multi-hole metal stent for malignant biliary obstruction in …
Tanoue K; Maruyama H; Shimamoto Y and 4 more (2024) - Transparency Score: 2/6
Anti-reflux mucosal ablation for refractory gastroesophageal reflux disease after Roux-en-Y gastric…
Ayoub F; Patel KK. (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest T. Kanesaka has received honoraria from Olympus, AstraZeneca, and AI Medical Service. R. Ishihara has received honoraria from Olympus, FUJIFILM Medical, Daiichi-Sankyo, Miyarisan Pharmaceutical, AI Medical Service, Astra Zeneca, MSD, and Ono Pharmaceutical. Y. Tani, K. Higashino, K. Aoki, T. Fujii, and T. Michida declare that they have no conflict of interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025